• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov17
Zymeworks Inc. Developing Novel Biologic Therapeutics for Refractory Diseases
12:07
Zymeworks Inc. Announces Positive Results from Ziihera's Phase III Clinical Trial for HER2-Positive Gastroesophageal Cancer
11:00
Nov7
Charles Zhu Maintains Buy Rating on Zymeworks
01:16
Zymeworks released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 27.61 M (forecast USD 29.91 M), actual EPS USD -0.26 (forecast USD -0.321)
00:00
Zymeworks released FY2025 9 Months earnings on November 6 After-Market EST, actual revenue USD 103.45 M, actual EPS USD -0.5342
00:00
Nov6
Zymeworks Inc. Releases Corporate Overview and Announces Future IND Application Plans
21:33

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 27.61 M, Net Income -19.6 M, EPS -0.2609

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 48.73 M, Net Income 2.317 M, EPS 0.0299

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 27.11 M, Net Income -22.64 M, EPS -0.3032

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ATGL
23.440
+160.16%
+14.430
FSHPR
0.1900
+58.07%
+0.070
WSHP
45.640
+51.08%
+15.430
AMIX
1.095
+50.62%
+0.373
PACS
15.425
+45.79%
+4.850
KWM
1.615
+40.39%
+0.500
ICG
1.460
+39.05%
+0.410
APLT
0.2999
+37.38%
+0.081
BNR
15.830
+34.84%
+4.090
ANVS
3.126
+33.57%
+0.786
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy